MIR

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).

Wall Street analysts forecast MIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MIR is 31.00 USD with a low forecast of 29.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Mirion Technologies Inc revenue for the last quarter amounts to 223.10M USD, increased 7.88 % YoY.

Mirion Technologies Inc. EPS for the last quarter amounts to 0.01 USD, decreased -114.29 % YoY.

Mirion Technologies Inc (MIR) has 2860 emplpoyees as of December 15 2025.

Today MIR has the market capitalization of 6.26B USD.